AUTISMDX
Live / Applied — Fourth extension granted (statement of use) (as of 11 Sept 2025)
What this means for you
Not registered yet, but its 19 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97555853
- Mark type
- Stylized text
- Filed
- 19 Aug 2022
- Published for opposition
- 18 Jul 2023
- Attorney of record
- Patrick C. Asplin
Goods and services
- Class 005 — Pharmaceuticals: Medical diagnostic test strips, patches, reagents and assays to determine disease activity in patients suffering from autism, Asperger's syndrome, and autism spectrum disorder; Medical diagnostic test strips, patches, reagents and assays for diagnosing autism, Asperger's syndrome, and autism spectrum disorder
- Class 044 — Medical, beauty and agricultural services: Medical information services, namely, providing reports and information relating to disease activity in individuals with autism, Asperger's syndrome, and autism spectrum disorder; providing reports and information relating to the best drug therapies and treatment options for individuals with autism, Asperger's syndrome, and autism spectrum disorder based on their genetic profile and gene expression
Owner
- Ampel, LLC, Charlottesville, VA, US
- Ampel, LLC, Charlottesville, VA, US
Prosecution history
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2025 — SOU EXTENSION 4 GRANTED
- 11 Sept 2025 — SOU EXTENSION 4 FILED
- 11 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2025 — SOU EXTENSION 3 GRANTED
- 11 Mar 2025 — SOU EXTENSION 3 FILED
- 11 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2024 — SOU EXTENSION 2 GRANTED
- 12 Sept 2024 — SOU EXTENSION 2 FILED
- 12 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 1 GRANTED